Key indicators: single-crystal X-ray study; T = 123 K; mean (C-C) = 0.005 Å; some non-H atoms missing; disorder in solvent or counterion; R factor = 0.045; wR factor = 0.109; data-to-parameter ratio = 16.3.
In the crystal structure of the title compound, [Cu(C 18 H 16 N 6 )(C 36 H 28 OP 2 )]PF 6 Á0.5CH 2 Cl 2 or [Cu(DPEPhos)(Bn-bta)]PF 6 Á0.5CH 2 Cl 2 {DPEPhos = bis [(diphenylphosphanyl) phenyl] ether and Bn-bta = 1,1 0 -dibenzyl-1H,1 0 H-4,4 0 -bi-1,2,3triazole}, the Cu atom is coordinated by two N and two P atoms of the ligands in a strongly distorted tetrahedral environment. There are two crystallographically independent complex cations present, which differ significantly in their geometrical parameters. The solvent molecule is disordered but satisfactory atomic positions could not be determined.
Related literature
For related literature, see: Monkowius et al. (2007) and references therein; Cosier & Glazer (1986) . For the treatment of disordered solvent, see: Spek (2003) .
Experimental
Crystal data [Cu(C 18 Table 1 Selected bond lengths (Å ). : ORTEP drawing of the structure of the cation containing Cu1 in crystals of the title compound (H atoms have been omitted for clarity). Displacement ellipsoids for non-H atoms are drawn at the 50% probability level. Fig. 3 . : ORTEP drawing of the structure of the cation containing Cu2. Displacement ellipsoids for non-H atoms are drawn at the 50% probability level.
{Bis [2-(diphenylphosphanyl) phenyl] ether-κ 2 P,P'} (1,1'-dibenzyl-1H,1'H-4,4'-bi-1,2,3-triazole-κ 2 
N,N')copper(I) hexafluoridophosphate dichloromethane hemisolvate
Crystal data [Cu(C 18 Triclinic, P1 Cell parameters were determined by indexing 8000 reflections with I/sigma limit 6.0. 
